About the Authors

Alexandre Guet-McCreight

Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing

alexandre.guet-mccreight@camh.ca (AGM); etay.hay@camh.ca (EH)

Affiliation Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Canada

Frank Mazza

Roles Methodology

Affiliations Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Canada, Department of Physiology, University of Toronto, Toronto, Canada

Thomas D. Prevot

Roles Conceptualization, Methodology, Writing – review & editing

Affiliations Department of Psychiatry, University of Toronto, Toronto, Canada, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada

Etienne Sibille

Roles Conceptualization, Methodology, Writing – review & editing

Affiliations Department of Psychiatry, University of Toronto, Toronto, Canada, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada, Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada

Etay Hay

Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

alexandre.guet-mccreight@camh.ca (AGM); etay.hay@camh.ca (EH)

Affiliations Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Canada, Department of Physiology, University of Toronto, Toronto, Canada, Department of Psychiatry, University of Toronto, Toronto, Canada

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: ES and TP are listed inventors on patents covering syntheses and use of α5-PAM compounds. EH, ES, and TP are listed inventors and AGM and FM are listed as collaborators on a patent covering in-silico EEG biomarkers for dosage determination and monitoring α5-PAM treatment efficacy. ES is Founder and CSO, and TP is Director of Preclinical Research and Development of Damona Pharmaceuticals, a biopharma dedicated to bringing α5-PAM compounds to the clinic.